Markus Raderer

18.2k total citations · 1 hit paper
324 papers, 11.9k citations indexed

About

Markus Raderer is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Markus Raderer has authored 324 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Pathology and Forensic Medicine, 164 papers in Oncology and 90 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Markus Raderer's work include Lymphoma Diagnosis and Treatment (164 papers), Neuroendocrine Tumor Research Advances (52 papers) and Chronic Lymphocytic Leukemia Research (47 papers). Markus Raderer is often cited by papers focused on Lymphoma Diagnosis and Treatment (164 papers), Neuroendocrine Tumor Research Advances (52 papers) and Chronic Lymphocytic Leukemia Research (47 papers). Markus Raderer collaborates with scholars based in Austria, Germany and United States. Markus Raderer's co-authors include Andreas Chott, Michael Hejna, Berthold Streubel, Werner Scheithauer, Barbara Kiesewetter, Stefan Wöhrer, Gabriela Kornek, Christoph Zielinski, Johannes Drach and Andrea Lamprecht and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Markus Raderer

310 papers receiving 11.6k citations

Hit Papers

Lanreotide in Metastatic ... 2014 2026 2018 2022 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
    2014 1.3k citations Marianne Pavel, Markus Raderer et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Markus Raderer 6.0k 5.5k 2.7k 2.5k 2.4k 324 11.9k
Rochelle E. Curtis 4.3k 0.7× 2.7k 0.5× 2.2k 0.8× 715 0.3× 2.3k 0.9× 109 11.2k
Joachim Yahalom 4.9k 0.8× 8.6k 1.6× 2.7k 1.0× 5.6k 2.2× 1.1k 0.5× 272 14.5k
Franco Cavalli 5.0k 0.8× 7.7k 1.4× 2.0k 0.7× 3.2k 1.3× 530 0.2× 190 11.6k
George P. Canellos 6.0k 1.0× 8.0k 1.5× 3.2k 1.2× 2.8k 1.1× 884 0.4× 209 15.8k
Ajay K. Gopal 5.3k 0.9× 4.4k 0.8× 1.2k 0.4× 1.1k 0.4× 1.1k 0.4× 391 11.5k
Won Seog Kim 6.3k 1.0× 7.1k 1.3× 999 0.4× 1.4k 0.6× 653 0.3× 462 10.8k
Catherine Thiéblemont 7.0k 1.2× 9.9k 1.8× 1.7k 0.6× 2.4k 1.0× 465 0.2× 420 14.3k
Terry L. Smith 7.7k 1.3× 2.9k 0.5× 2.6k 1.0× 514 0.2× 989 0.4× 154 16.0k
Hanneke C. Kluin‐Nelemans 4.5k 0.7× 6.5k 1.2× 1.6k 0.6× 1.7k 0.7× 684 0.3× 376 14.0k
Ian Magrath 5.1k 0.8× 3.8k 0.7× 1.2k 0.4× 999 0.4× 761 0.3× 173 9.7k

Countries citing papers authored by Markus Raderer

Since Specialization
Citations

This map shows the geographic impact of Markus Raderer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Raderer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Raderer more than expected).

Fields of papers citing papers by Markus Raderer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Raderer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Raderer. The network helps show where Markus Raderer may publish in the future.

Co-authorship network of co-authors of Markus Raderer

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Raderer. A scholar is included among the top collaborators of Markus Raderer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Raderer. Markus Raderer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rendl, Gundula, Jan Marco Kern, Lenka Bašková, et al.. (2025). Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei. Haematologica. 111(3). 1120–1124.
2.
Pavel, Marianne, Harald Lahner, Dieter Hörsch, et al.. (2024). Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study. The Oncologist. 29(5). e643–e654. 4 indexed citations
3.
Mair, Maximilian J., Rainer Puhr, Marlene Troch, et al.. (2023). Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. Infectious Agents and Cancer. 18(1). 9–9. 1 indexed citations
4.
Zeilinger, Elisabeth L., Matthias Knefel, Jakob Pietschnig, et al.. (2023). The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients. International Journal of Clinical and Health Psychology. 23(4). 100404–100404. 2 indexed citations
5.
Kosmala, Aleksander, Toru Higuchi, Philipp E. Hartrampf, et al.. (2023). CXCR4-gerichtete PET/CT in 100 Patient:innen mit Marginalzonenlymphom -Diagnostische Performance, Vorhersagepotenzial und Eignung für CXCR4-Endoradiotherapie. Nuklearmedizin - NuclearMedicine. 62(2). 95–95. 1 indexed citations
6.
Zeilinger, Elisabeth L., Ingo W. Nader, Wolfgang Wiedermann, et al.. (2022). Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatients. International Journal of Clinical and Health Psychology. 22(3). 100315–100315. 8 indexed citations
7.
Moik, Florian, et al.. (2022). ABO blood group type and risk of venous thromboembolism in patients with cancer. Blood Advances. 6(24). 6274–6281. 22 indexed citations
8.
Zeilinger, Elisabeth L., Simone Lubowitzki, Matthias Unseld, et al.. (2022). The impact of COVID‐19 on cancer care of outpatients with low socioeconomic status. International Journal of Cancer. 151(1). 77–82. 13 indexed citations
9.
Mayerhoefer, Marius E., Markus Raderer, Wolfgang Lamm, et al.. (2021). CXCR4 PET/MRI for follow-up of gastric mucosa–associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication. Blood. 139(2). 240–244. 28 indexed citations
10.
11.
Taghizadeh, Hossein, Matthias Unseld, Robert M. Mader, et al.. (2020). Targeted Therapy Recommendations for Therapy Refractory Solid Tumors—Data from the Real-World Precision Medicine Platform MONDTI. Journal of Personalized Medicine. 10(4). 188–188. 7 indexed citations
12.
Rendl, Gundula, Alexander Becherer, Christian Trummer, et al.. (2020). Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria. International Journal of Endocrinology. 2020. 1–8. 26 indexed citations
13.
Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2015). Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients. Clinical Cancer Research. 21(11). 2506–2513. 66 indexed citations
14.
Schiefer, Ana‐Iris, Christoph Kornauth, Ingrid Simonitsch‐Klupp, et al.. (2015). Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas. Medicine. 94(52). e2388–e2388. 19 indexed citations
15.
Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2014). Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients. Clinical Cancer Research. 20(11). 2984–2993. 81 indexed citations
16.
Atamaniuk, Johanna, Andreas Gleiß, Edit Porpaczy, et al.. (2012). Overexpression of G protein‐coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma. European Journal of Clinical Investigation. 42(9). 953–960. 101 indexed citations
17.
Streubel, Berthold, Elisabeth Kretschmer‐Chott, Andreas Püspök, et al.. (2011). Primary Follicular Lymphoma of the Duodenum Is a Distinct Mucosal/Submucosal Variant of Follicular Lymphoma: A Retrospective Study of 63 Cases. Journal of Clinical Oncology. 29(11). 1445–1451. 152 indexed citations
18.
Ruskoné-Fourmestraux, A., Wolfgang Fischbach, B.M.P. Aleman, et al.. (2011). EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 60(6). 747–758. 245 indexed citations
19.
Troch, Marlene, Constanze Jonak, Leonhard Müllauer, et al.. (2009). A phase II study of bortezomib in patients with MALT lymphoma. Haematologica. 94(5). 738–742. 45 indexed citations
20.
Streubel, Berthold, Gerhard Seitz, M Stolte, et al.. (2006). MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas. Gut. 55(11). 1581–1585. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rochelle E. Curtis Breakdown of academic impact, for papers by Joachim Yahalom Breakdown of academic impact, for papers by Franco Cavalli Breakdown of academic impact, for papers by George P. Canellos Breakdown of academic impact, for papers by Ajay K. Gopal Breakdown of academic impact, for papers by Won Seog Kim Breakdown of academic impact, for papers by Catherine Thiéblemont Breakdown of academic impact, for papers by Terry L. Smith Breakdown of academic impact, for papers by Hanneke C. Kluin‐Nelemans Breakdown of academic impact, for papers by Ian Magrath
Rankless by CCL
2026